A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic Function

NCT04116476 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment

NCT04293029 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study of Abiraterone Acetate in Patients With Severe Hepatic Impairment Compared to Patients With Normal Hepatic Function

NCT01516047 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics Of Jaktinib In Subjects With Hepatic Impairment And Normal Hepatic Function

NCT04993404 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study of CXB909 in Healthy Male Subjects

NCT01505907 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

KD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment

NCT04166942 ·Status: COMPLETED ·Phase: PHASE1

Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment

NCT06674915 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects

NCT05391724 ·Status: COMPLETED ·Phase: PHASE1

Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic Gallstones

NCT00576589 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of Cenobamate in Subjects With Normal Hepatic Function and Subjects With Severe Hepatic Impairment

NCT04791553 ·Status: COMPLETED ·Phase: PHASE1

Effect Of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of PF-06865571 In Subjects With Hepatic Impairment and in Healthy Subjects

NCT04091061 ·Status: COMPLETED ·Phase: PHASE1

GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers

NCT05814926 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy Subjects

NCT02207595 ·Status: COMPLETED ·Phase: PHASE1

Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis

NCT01359462 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Safety of Cedirogant and How Cedirogant Moves Through the Body in Adult Participants With Mild, Moderate and Severe Hepatic Impairment

NCT05376839 ·Status: TERMINATED ·Phase: PHASE1

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function

NCT05283915 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic Impairment

NCT05599932 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of BAF312 in Patients With Hepatic Impairment

NCT01565902 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects

NCT05711797 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment

NCT03289234 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Mitiperstat in Participants With Hepatic Impairment

NCT05751759 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

NCT06390410 ·Status: COMPLETED ·Phase: PHASE1

Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy Participants

NCT04991571 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Investigate the Pharmacokinetics, Safety and Tolerability Following Single Administration of CHF6001 in Subjects With Mild, Moderate and Severe Liver Impairment in Comparison With Matched Healthy Control Subjects

NCT05373953 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Dabrafenib in Subjects With Hepatic Impairment

NCT02873650 ·Status: TERMINATED ·Phase: PHASE1